image
Eagle Pharmaceuticals, Inc. EGRX
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 0.9
12.7 %
$ 11.7 M
Market Cap
1.06
P/E
INCOME STATEMENT
317 M REVENUE
84.56%
Growth Rates
1Year 84.56%
3Years 17.36%
5Years 5.99%
7Years 25.05%
10Years 62.03%
53.5 M OPERATING INCOME
1935.02%
Growth Rates
1Year 1935.02%
3Years 34.82%
5Years -6.30%
7Years 54.36%
10Years 16.73%
-2.67 M NET INCOME
-7.48%
Growth Rates
1Year -7.48%
3Years -6.92%
5Years -1.62%
7Years -0.46%
10Years 7.87%
EFFICIENCY
Earnings Waterfall Eagle Pharmaceuticals, Inc.
image
Revenue 317 M
Cost Of Revenue 94.9 M
Gross Profit 222 M
Operating Expenses 141 M
Operating Income 53.5 M
Other Expenses 56.1 M
Net Income -2.67 M

Income Statement

Millions
Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Sep-2014 Sep-2013 Sep-2012
REVENUE
Revenue 316.6 171.5 187.8 195.9 213.3 236.7 189.5 66.2 19.1 13.7 2.5
GROSS PROFIT
Cost Of Revenue 94.9 42.2 45.5 60.9 61.9 57.2 55.3 15.6 11.7 7.4 3.2
Gross Profit 221.7 129.4 142.3 135.0 151.4 179.5 134.2 50.6 7.4 6.3 (0.6)
OPERATING INCOME
Operating Expenses 140.7 126.6 109.4 113.2 104.9 104.0 82.6 48.0 26.1 14.8 19.2
Selling, General and Administrative Expenses 106.6 75.3 78.6 76.4 60.5 71.4 52.3 20.2 9.3 5.0 6.4
Research and Development Expenses 34.1 51.3 30.8 36.8 44.4 32.6 30.3 27.9 16.8 9.8 12.8
Operating Income 53.5 (2.9) 25.3 21.8 36.6 74.0 53.4 2.6 (18.8) (8.5) (19.8)
PRE-TAX INCOME
Interest Income Expense 4.0 1.6 2.6 2.7 2.7 1.1 8 K 11 K 8 K 1.4 0.3
Total Other Income 8.0 (7.3) (10.3) 0.2 (2.6) (1.0) 76 K 14 K (0.5) 1.5 (0.3)
Pre-Tax Income 61.4 (4.5) 22.7 22.0 34.0 72.9 53.4 2.6 (19.3) (6.9) (20.2)
NET INCOME
Tax Provision 25.8 4.1 10.7 7.7 2.1 21.0 (28.0) 3 K (1.3) (0.9) (0.8)
Net Income 35.6 (8.6) 12.0 14.3 31.9 51.9 81.5 2.6 (18.0) (6.0) (19.4)
EPS 2.76 0.66 0.89 1.04 2.16 3.44 5.24 0.17 1.81 0.57 1.83